Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1995; 26:1202-1208
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heller, G.
Right arrow Articles by McClellan
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heller, G.
Right arrow Articles by McClellan, , JR

Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions

GV Heller, SD Herman, MI Travin, JI Baron, C Santos-Ocampo, and McClellan JR

Nuclear Cardiology Laboratory, Hartford Hospital, Connecticut 06102, USA.

OBJECTIVES. This study sought to establish the prognostic value of intravenous dipyridamole technetium-99m (Tc-99m) sestamibi single-photon emission computed tomographic (SPECT) myocardial perfusion imaging. BACKGROUND. Optimal management of patients with coronary artery disease involves strategies designed to reduce the risk of myocardial infarction and cardiac death. The role of myocardial perfusion imaging using newer clinical techniques to determine risk and possible benefit from therapy has not been evaluated. METHODS. Myocardial imaging results were classified as normal or abnormal (fixed or reversible defects; small, moderate or large). Follow-up evaluation of all patients included the occurrence of cardiac death or nonfatal myocardial infarction and other cardiac-related hospital admissions. RESULTS. During a mean (+/- SD) follow-up period of 12.8 +/- 6.8 months in 512 patients, 25 had a cardiac event. Patients with abnormal perfusion had significantly more cardiac events than those with normal perfusion (22 vs. 3, p < 0.01). Patients with reversible defects had the highest event rates (8.6%), and those with normal study results had a very low event rate (1.4%). Large defects were strongly associated with more cardiac events and hospital admissions than either normal scan results or abnormal results showing small defects. CONCLUSIONS. Patients with normal study results or a small defect after intravenous dipyridamole Tc-99m sestamibi SPECT imaging had an excellent short-term prognosis. Those with abnormal results (reversible or large defect) had an increased risk of subsequent cardiac death, nonfatal myocardial infarction and other cardiac-related hospital admissions.


This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
R. J. Gibbons
Noninvasive Diagnosis and Prognosis Assessment in Chronic Coronary Artery Disease: Stress Testing With and Without Imaging Perspective
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 257 - 269.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Yoshinaga, B. J.W. Chow, K. Williams, L. Chen, R. A. deKemp, L. Garrard, A. Lok-Tin Szeto, M. Aung, R. A. Davies, T. D. Ruddy, et al.
What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography?
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1029 - 1039.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Hachamovitch, S. W. Hayes, J. D. Friedman, I. Cohen, and D. S. Berman
A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 722 - 729.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al.
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association
Circulation, February 8, 2005; 111(5): 682 - 696.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. D. Leslie, S. A. Tully, M. S. Yogendran, L. M. Ward, K. A. Nour, and C. J. Metge
Prognostic Value of Automated Quantification of 99mTc-Sestamibi Myocardial Perfusion Imaging
J. Nucl. Med., February 1, 2005; 46(2): 204 - 211.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Berman, N. D. Wong, H. Gransar, R. Miranda-Peats, J. Dahlbeck, S. W. Hayes, J. D. Friedman, X. Kang, D. Polk, R. Hachamovitch, et al.
Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 923 - 930.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Abidov, J. J. Bax, S. W. Hayes, R. Hachamovitch, I. Cohen, J. Gerlach, X. Kang, J. D. Friedman, G. Germano, and D. S. Berman
Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1818 - 1825.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N K Sabharwal and A Lahiri
Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease
Heart, November 1, 2003; 89(11): 1291 - 1297.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Abidov, R. Hachamovitch, S. W. Hayes, C. K. Ng, I. Cohen, J. D. Friedman, G. Germano, and D. S. Berman
Prognostic Impact of Hemodynamic Response to Adenosine in Patients Older Than Age 55 Years Undergoing Vasodilator Stress Myocardial Perfusion Study
Circulation, June 17, 2003; 107(23): 2894 - 2899.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Hachamovitch, S. Hayes, J. D. Friedman, I. Cohen, L. J. Shaw, G. Germano, and D. S. Berman
Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan?
J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1329 - 1340.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Berman, X. Kang, S. W. Hayes, J. D. Friedman, I. Cohen, A. Abidov, L. J. Shaw, A. M. Amanullah, G. Germano, and R. Hachamovitch
Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: Impact of diabetes mellitus on incremental prognostic value and effect on patient management
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1125 - 1133.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, J. R.T.C. Roelandt, and D. Poldermans
Prognostic Value of Dobutamine-Atropine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Patients with Known or Suspected Coronary Artery Disease
J. Nucl. Med., June 1, 2002; 43(6): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. A. J. Chamuleau, R. A. Tio, C. C. de Cock, E. D. de Muinck, N. H. J. Pijls, B. L. F. van Eck-Smit, K. T. Koch, M. Meuwissen, M. G. W. Dijkgraaf, A. de Jong, et al.
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. D. Miller
Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 859 - 863.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Calnon, P. D. McGrath, A. L. Doss, F. E. Harrell Jr, D. D. Watson, and G. A. Beller
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1511 - 1517.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Taki, S. Fujino, K. Nakajima, I. Matsunari, H. Okazaki, T. Saga, H. Bunko, and N. Tonami
99mTc-Sestamibi Retention Characteristics During Pharmacologic Hyperemia in Human Myocardium: Comparison with Coronary Flow Reserve Measured by Doppler Flowire
J. Nucl. Med., October 1, 2001; 42(10): 1457 - 1463.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. T. Mast, L. K. Shaw, G. C. Ravizzini, M. Chambless, P. Joski, R. E. Coleman, and S. Borges-Neto
Incremental Prognostic Value of RNA Ejection Fraction Measurements During Pharmacologic Stress Testing: A Comparison with Clinical and Perfusion Variables
J. Nucl. Med., June 1, 2001; 42(6): 871 - 877.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. P. Mandalapu, M. Amato, and H. G. Stratmann
Technetium Tc 99m Sestamibi Myocardial Perfusion Imaging: Current Role for Evaluation of Prognosis
Chest, June 1, 1999; 115(6): 1684 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Iskander and A. E. Iskandrian
Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. M. Wagdy, D. Hodge, T. F. Christian, T. D. Miller, and R. J. Gibbons
Prognostic Value of Vasodilator Myocardial Perfusion Imaging in Patients With Left Bundle-Branch Block
Circulation, April 28, 1998; 97(16): 1563 - 1570.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement